FDA Approved: STARJEMZA — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved STARJEMZA (ustekinumab-hmny) from Hikma Pharmaceuticals USA Inc. as a biosimilar to ustekinumab, enabling marketing for the same indications as the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Plaque Psoriasis
• Psoriatic Arthritis
• Ulcerative Colitis

Drugs mentioned

• STARJEMZA (USTEKINUMAB-HMNY)

Snippet

ORIG AP for STARJEMZA (USTEKINUMAB-HMNY)